Sapience Therapeutics
Clinical trials sponsored by Sapience Therapeutics, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug ST101 takes on Hard-to-Treat cancers Results expected Dec 2026 (estimated)
- Can a new drug ST316 shrink Hard-to-Treat tumors? Results expected Dec 2026 (estimated)